Transient synovitis affecting multiple joint sites simultaneously, classified under other disorders of synovium and tendon.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M67.39.
Source · Editorial brief grounded in 5 cited references ↓
- Explicitly name each affected joint in the clinical note — vague language like 'multiple joints' without identification risks downcoding to M67.38 (other site) or an unspecified code.
- Record the onset, duration, and self-limiting nature of symptoms at each site to support transient synovitis over infectious or inflammatory arthropathy diagnoses.
- Document imaging results (ultrasound or MRI) confirming joint effusion or synovial thickening at each involved site to substantiate multi-site involvement.
- Note any prior workup ruling out septic arthritis, reactive arthritis, or juvenile idiopathic arthritis — payers may scrutinize multi-site transient synovitis without supporting differential documentation.
- If conservative treatment (NSAIDs, rest, physical therapy) was initiated, document that at each affected joint to establish medical necessity for the encounter.
Related CPT procedures
Procedure codes commonly billed with M67.39. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M67.39 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M67.39 when only one joint is involved — if documentation names a single joint, use the site-specific and laterality-specific M67.3x code instead.
- Stacking multiple single-site M67.3x codes alongside M67.39 for the same encounter — M67.39 already captures multi-site involvement; duplicate site codes create claim redundancy and audit risk.
- Confusing transient synovitis with infectious synovitis (M65.0x) or villonodular synovitis (M12.2x) — the underlying pathology must be documented as transient and non-infectious before assigning any M67.3x code.
- Failing to distinguish M67.39 from M67.38 (other site) — M67.38 is for a single site not listed elsewhere, not for multiple sites.
- Omitting a secondary code for any underlying condition if the synovitis is secondary to a systemic disorder — transient synovitis is typically idiopathic, but document if a contributing cause is identified.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M67.39 is the correct code when transient synovitis is documented at two or more distinct joint sites and no single-site code captures the full clinical picture. Transient synovitis is a self-limiting inflammatory condition of the synovial lining, typically presenting with joint effusion, pain, and reduced range of motion. When involvement spans multiple joints — for example, concurrent hip and knee, or wrist and ankle — M67.39 is the appropriate billable code rather than assigning multiple single-site M67.3x codes.
Within the M67.3 hierarchy, site-specific codes (M67.31–M67.37, M67.38) take precedence when only one joint is affected. Reserve M67.39 strictly for documented multi-site involvement. If the encounter note names only one joint, use the laterality-specific code for that site. M67.39 carries no laterality extension because by definition it spans more than one anatomic location.
M67.39 maps to MS-DRG 557 (Tendonitis, myositis and bursitis with MCC) or 558 (without MCC) under DRG v43.0. This code falls within the soft tissue disorders section (M65–M67) of Chapter 13. No 7th-character extension is required — M67.39 is a complete, billable code as stated.
Sibling codes
Other billable codes under M67.3 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When should I use M67.39 instead of multiple individual M67.3x codes?
02Does M67.39 require a 7th-character extension?
03Can M67.39 be used for pediatric patients with transient synovitis of the hip plus another joint?
04What is the difference between M67.38 and M67.39?
05Which MS-DRGs does M67.39 map to?
06Should I code the underlying cause separately when reporting M67.39?
07Is M67.39 valid for outpatient and inpatient claims?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 — https://www.cdc.gov/nchs/icd/icd10cm.htm
- 02icd10data.com — 2026 ICD-10-CM Diagnosis Code M67.39: https://www.icd10data.com/ICD10CM/Codes/M00-M99/M65-M67/M67-/M67.39
- 03icd10data.com — 2026 ICD-10-CM Codes M67*: https://www.icd10data.com/ICD10CM/Codes/M00-M99/M65-M67/M67-
- 04CMS MS-DRG v43.0 Grouper
- 05PMC — ICD-10 Coding of Musculoskeletal Conditions in the Veterans Health Administration: https://pmc.ncbi.nlm.nih.gov/articles/PMC8783617/
Mira AI Scribe
Mira AI Scribe captures the specific joints involved, laterality at each site, symptom onset and duration, imaging findings (effusion, synovial thickening), and documentation of differential diagnosis workup excluding infectious or inflammatory arthropathy. This prevents vague multi-joint documentation that forces a coder to default to an unspecified code, which can trigger payer scrutiny and medical necessity denials.
See how Mira captures M67.39 documentation